In CKD patients, plasma syndecan-1 level was detected in patients with stage 4 CKD, whereas increased HA level was observed only in patients with stage 5 CKD suggesting that shedding of HA occurs later than that of syndecan-1 and may be indicative of more severe injury to the kidney (123). This evidence concerns the gene SDC1 and chronic kidney disease.